Polymedco is an innovative company that often leads the marketplace with new products. The company has been equally successful in developing new markets, as well as expanding existing markets that are left untapped of their full potential. In 1995, Polymedco introduced a magnetic separation method for HDL which proved to be a breakthrough in conventional testing means for cholesterol. In 1996, the company introduced its Sed-Chek® 2 ESR control which became the product leader in sedrate controls and encouraged the use of quality control procedures. In 1997, Polymedco worked closely with Biomira and received FDA clearance for the Truquant BR® breast tumor marker which brought a new method of testing to breast cancer patients. In 1999, Polymedco’s BTA stat® test for recurrent bladder cancer detection received FDA clearance for prescription home use. The recent market introduction of the Poly-Chem™ Chemistry/Immunoassay analyzer marks Polymedco’s latest marketing achievement. This compact and technically advanced counter top instrument offers users the most extensive menu on the market and the ability to consolidate work stations.
In July of 1998, Polymedco purchased Bard Diagnostic Sciences (renamed Alidex, Inc.), a diagnostic subsidiary of C.R. Bard. With this addition, Polymedco maintains an ISO 9001 manufacturing and research facility located in Redmond, Washington.
Polymedco’s success lies in its ability to select innovative and competitive products, develop strong sales and marketing strategies, and maintain a high level of technical and customer support. As Polymedco continues to grow, we continue to search out new products and new market opportunities. Look to Polymedco to meet your clinical laboratory needs.
Polymedco competes in the following markets:
Chemistry: Poly-Chem™ chemistry/immunoassay analyzer with extensive reagent menu; Lipi+Plus® Direct HDL and Direct LDL, Magnetic HDL and Magnetic LDL, and a complete line of Chemistry reagents, available in bulk, as well as dedicated packaging.
Special Chemistries: Complete line of assays for Diabetes, Rheumatology, Immunology, and Infectious Disease. These products are available in bulk form as well as dedicated instrument packaging, including for Dimension® systems.
Comprehensive Lipids: The most complete line of esoteric lipid assays including Apolipoprotein A-I, A-II, B, C-II, C-III, E, as well as NEFA and Lp(a). Exclusive immunoseparation assay for Remnant Lipoprotein-Cholesterol, (RLP-C), is also available.
Diabetes Products: The most comprehensive line of Diabetes testing kits including tests for Microalbumin, Glucose, Fructosamine, and Hemoglobin A1c.
Hematology: Complete, industry leading, line of sedrate products and controls, including Sediplast® manual ESR system, Sedimat® 15 automated ESR reader, and Sed-Chek® 2 ESR control.
Tumor Markers: BTA stat® test for qualitative and BTA TRAK® for quantitative recurrent bladder cancer detection. Our RIA tumor markers include Truquant BR (CA 27.29) for breast cancer, CA 15-3, CA 125II, and CA19-9. Additional EIA markers include CASA, NSE, Free PSA, and CA242.
Poly stat™ Point of Care Tests: Waived and Moderately Complex cassette tests for hCG, Mono, H. Pylori, and Strep A.
For information on Polymedco's complete product line, visit our web site at www.polymedco.com, or call us at 1-800-431-2123 or (914) 739-5400!
Dimension is a Registered Trademark of Dade Behring, Inc.